Cleveland BioLabs
CBLI
#9803
Rank
NZ$84.74 M
Marketcap
NZ$5.47
Share price
-7.31%
Change (1 day)
N/A
Change (1 year)

Market capitalization of Cleveland BioLabs (CBLI)

Last known market cap: NZ$84.74 Million

As of December 2025 Cleveland BioLabs has a market cap of NZ$84.74 Million. This makes Cleveland BioLabs the world's 9803th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Cleveland BioLabs from 2006 to 2022

End of year Market Cap

Year Marketcap Change
2022NZ$77.28 M7.58%
2021NZ$71.83 M15.43%
2020NZ$62.23 M516.26%
2019NZ$10.09 M-40.64%
2018NZ$17.01 M-73.29%
2017NZ$63.68 M182.76%
2016NZ$22.52 M-59.8%
2015NZ$56.02 M169.45%
2014NZ$20.79 M-67.68%
2013NZ$64.32 M-11.05%
2012NZ$72.31 M-44.43%
2011NZ$0.13 B-51.98%
2010NZ$0.27 B194.35%
2009NZ$92.07 M83.16%
2008NZ$50.26 M-66.08%
2007NZ$0.14 B75.15%
2006NZ$84.6 M

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Onconova Therapeutics
ONTX
NZ$36.1 M-57.40%๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
NZ$1.87 B 2,116.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$293.28 B 346,002.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$434.73 B 512,914.06%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Bristol-Myers Squibb
BMY
NZ$180.04 B 212,361.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$203.43 B 239,972.28%๐Ÿ‡ซ๐Ÿ‡ท France
GlaxoSmithKline
GSK
NZ$168.87 B 199,183.34%๐Ÿ‡ฌ๐Ÿ‡ง UK
Soligenix
SNGX
NZ$27.86 M-67.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$1.538 T 1,815,244.38%๐Ÿ‡บ๐Ÿ‡ธ USA